Clinical trial
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 is registered in ClinicalTrials.gov with St. Jude Children's Research Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Familial Investigations of Childhood Cancer Predisposition
- Lead sponsor
- St. Jude Children's Research Hospital
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 6, 2017
- Completion date
- March 31, 2037
- Enrollment
- 1,500 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
acute leukemia, adenomatous polyposis, adrenocortical carcinoma, aml, bap1 tumor predisposition syndrome, carney complex, choroid plexus carcinoma, constitutional mismatch repair deficiency syndrome, diamond-blackfan anemia, dicer1 syndrome, dyskeratosis congenita, emberger syndrome, familial acute myeloid leukemia, familial adenomatous polyposis, familial cancer, familial neuroblastoma, familial wilms tumor, fanconi anemia, gist, hereditary breast and ovarian cancer, hereditary paraganglioma-pheochromocytoma syndrome, hodgkin lymphoma, juvenile polyposis, li-fraumeni syndrome, lynch syndrome, mds, melanoma syndrome, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, neuroblastoma, neurofibromatosis type 1, neurofibromatosis type ii, nevoid basal cell carcinoma syndrome, non hodgkin lymphoma, noonan syndrome and other rasopathy, overgrowth syndromes, pancreatic cancer, peutz-jeghers syndrome, pheochromocytoma/paraganglioma, pten hamartoma tumor syndrome, retinoblastoma, rhabdoid tumor predisposition syndrome, rhabdomyosarcoma, rothmund-thomson syndrome, tuberous sclerosis, von hippel-lindau disease